Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

55.01USD
26 Nov 2014
Price Change (% chg)

$0.84 (+1.55%)
Prev Close
$54.17
Open
$53.96
Day's High
$55.22
Day's Low
$53.90
Volume
1,086,448
Avg. Vol
889,077
52-wk High
$56.59
52-wk Low
$38.26

Search Stocks
POPS RICHARD F
Trading Date Type Shares Traded Price Shares Held
12 Nov 2014 Buy 50,000 $14.90 520,063
12 Nov 2014 Sell 50,000 $52.88 520,063
11 Nov 2014 Buy 50,000 $14.90 520,063
11 Nov 2014 Sell 50,000 $52.86 520,063
15 Oct 2014 Sell 31,800 $41.34 520,063
15 Oct 2014 Sell 18,200 $40.90 520,063
15 Oct 2014 Buy 50,000 $14.90 520,063
14 Oct 2014 Sell 37,300 $40.91 520,063
14 Oct 2014 Sell 12,700 $41.50 520,063
14 Oct 2014 Buy 50,000 $14.90 520,063
16 Sep 2014 Sell 50,000 $44.89 520,063
16 Sep 2014 Buy 50,000 $14.90 520,063
1 Jul 2014 Sell 48,600 $51.68 520,063
1 Jul 2014 Buy 50,000 $12.30 520,063
1 Jul 2014 Sell 1,400 $52.07 520,063
24 Jun 2014 Sell 49,800 $49.87 520,063
24 Jun 2014 Buy 50,000 $12.30 520,063
24 Jun 2014 Sell 200 $50.70 520,063
17 Jun 2014 Sell 1,300 $47.51 520,063
17 Jun 2014 Buy 41,870 $12.30 520,063
17 Jun 2014 Buy 8,130 $12.30 520,063
17 Jun 2014 Sell 48,700 $46.70 520,063
27 May 2014 Sell 6,484 $45.74 520,063
27 May 2014 Buy 13,750 $0.00 520,063
20 May 2014 Buy 8,125 $0.00 512,797

Institutional Holders

% Shares Owned: 97.26%
# of Holders: 273
Total Shares Held: 142,227,450
3 Mo. Net Change: 218,463
# New Positions: 23
# Closed Positions: 34
# Increased Positions: 120
# Reduced Positions: 126
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

Richard Pops

51 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

51 2011 President

James Frates

46 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

56 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

55 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Rebecca Peterson

38 Senior Vice President, Corporate Communications

Elliot Ehrich

55 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

60 2011 Senior Vice President - Corporate Development

Mark Stejbach

50 2012 Senior Vice President, Chief Commercial Officer

Paul Mitchell

61 2012 Lead Independent Director

Nancy Wysenski

56 2013 Director

David Anstice

65 2011 Independent Director

Floyd Bloom

77 2011 Independent Director

Robert Breyer

70 2011 Independent Director

Wendy Dixon

58 2011 Independent Director

Geraldine Henwood

60 2011 Independent Director
Search Stocks